Share This Page
Contact
- Herceptin Access Solutions
- Phone: (888) 249-4918
- Fax: (888) 249-4919
- Web: www.HerceptinAccessSolutions.com
Herceptin Access Solutions is a reimbursement resource designed to address the informational needs of patients on Genentech products related to reimbursement. Herceptin Access Solutions provides information to doctors, on their patient's behalf, in order to help obtain timely reimbursement.
- Genentech Corporate Headquarters
- Phone: (650) 225-1000
- Fax: (650) 225-6000
- Mail: Genentech, Inc.
- 1 DNA Way, Mail Stop #210
- South San Francisco, CA 94080-4990
- Additional Genentech Contact Information is available at:
- www.gene.com/gene/contact/telephone.html
- Patients outside of the United States
- Web: www.roche.com
Herceptin® (trastuzumab)
- Home
- HER2 and Breast Cancer Education
- Adjuvant Treatment
- Metastatic Treatment
- Community
- Resource Center
- What do Adjuvant and Metastatic mean? Learn more.
Adjuvant Care Is defined as additional treatment given after the main treatment plan to decrease the chance of recurrence. Adjuvant therapy for breast cancer can include chemotherapy, hormone therapy, radiation therapy, or biological therapy
Metastatic Breast Cancer Breast cancer that has spread to other sites in the body; also referred to as invasive or infiltrating
